Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;25(9):684-688.e4.
doi: 10.1016/j.clml.2025.04.005. Epub 2025 Apr 14.

Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma

Jules Higué  1 , Gaetan Basile  2 , Titouan Cazaubiel  2 , Julie Gay  3 , Guillaume Béziat  4 , Martin Gauthier  5 , Miguel Carreiro  6 , Noémie Gadaud  7 , François Lifermann  8 , Reza Tabrizi  9 , Benjamin Hébraud  10 , Miguel Granell  10 , Léopoldine Lapierre  10 , Pierre-Luc Mouchel  10 , Pierre Bories  10 , Jill Corre  10 , Cyrille Hulin  2 , Aurore Perrot  10
Affiliations

Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma

Jules Higué et al. Clin Lymphoma Myeloma Leuk. 2025 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure Pierre Bories declares honoraria from Abbvie, BMS-Celgene, Kite-Gilead, Novartis and Servier. Titouan Cazaubiel declares honoraria from BMS, Janssen and Sanofi. Jill Corre declares honoraria from Abbvie, Amgen, BMS, Janssen, Pfizer, Sanofi and Takeda. Julie Gay declares honoraria from Amgen, Janssen and Sanofi. Cyrille Hullin declares honoraria from BMS, Janssen and Sanofi. Aurore Perrot declares honoraria from Abbvie, Adaptive, Amgen, BMS, GSK, Janssen, Pfizer, Sanofi and Takeda. All other authors declare no competing interests.